EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
Medical Devices Regulation - Hazardous Substances
EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020
This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).
Last updated 15 listopada 2024. Database contains 4918 unique substances/entries.
Filter the list
|
show/hide
1,2,4-triazolidine-3,5-dione, compound with hydrazine (1:1)
EC / List no:
264-246-2
| CAS no:
63467-96-9
|
-
|
-
|
Carc. 1B; Acute Tox. 3; Skin Sens. 1 |
Details | ||
|
-
|
-
|
Acute Tox. 4 |
Details | |||
|
-
|
-
|
Acute Tox. 4 |
Details | |||
|
-
|
-
|
Acute Tox. 3; STOT RE 2 |
Details | |||
|
-
|
-
|
Acute Tox. 4 |
Details | |||
|
show/hide
|
-
|
-
|
Repr. 2; Acute Tox. 2; Acute Tox. 3; Skin Sens. 1 |
Details | ||
|
-
|
-
|
Carc. 1A; Acute Tox. 4 |
Details | |||
|
show/hide
|
-
|
-
|
Carc. 1A; Acute Tox. 4 |
Details | ||
|
-
|
-
|
Acute Tox. 2 |
Details | |||
|
show/hide
Benzenesulfonic acid, 2(or 4)-methyl-, compd. with benzenamine (1:1)
EC / List no:
-
| CAS no:
70788-38-4
|
-
|
-
|
Carc. 2; Muta. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1; Skin Sens. 1 |
Details | ||
|
-
|
-
|
Acute Tox. 2 |
Details | |||
|
show/hide
Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, mono(dodecylbenzenesulfonate)
EC / List no:
-
| CAS no:
82794-01-2
4,4'-carbonimidoylbis(N,N-dimethylaniline) monohydrochloride
EC / List no:
219-567-2
| CAS no:
2465-27-2
Decyl hydrogen sulphate, compound with 4,4'-carbonimidoylbis[N,N-dimethylaniline] (1:1)
EC / List no:
281-828-1
| CAS no:
84030-53-5
4,4'-bis[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo][1,1'-biphenyl]-2,2'-disulphonic acid, compound with 4,4'-carbonimidoylbis[N,N-dimethylphenylamine] (1:2)
EC / List no:
277-106-0
| CAS no:
72939-51-6
Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, monohydrochloride, 2-hydroxyethanesulfonate
EC / List no:
-
| CAS no:
86157-51-9
Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, monohydrochloride, (2-methoxyethoxy)acetate
EC / List no:
-
| CAS no:
82941-28-4
|
-
|
-
|
Carc. 2; Acute Tox. 4; Eye Irrit. 2 |
Details | ||
|
show/hide
|
-
|
-
|
Carc. 1B; Acute Tox. 4 |
Details | ||
|
show/hide
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, mono(3,5-dinitrobenzoate)
EC / List no:
-
| CAS no:
92415-53-7
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, mono(2-hydroxy-3,5-dinitrobenzoate)
EC / List no:
-
| CAS no:
92415-48-0
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, bis(3,5-dinitrobenzoate)
EC / List no:
-
| CAS no:
92415-38-8
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, bis(2-hydroxy-3,5-dinitrobenzoate)
EC / List no:
-
| CAS no:
92415-49-1
|
-
|
-
|
Carc. 1B; Acute Tox. 4 |
Details | ||
|
-
|
-
|
Carc. 1B; Acute Tox. 4; Skin Sens. 1 |
Details | |||
|
show/hide
|
-
|
-
|
Carc. 1A; Acute Tox. 4 |
Details | ||
|
-
|
-
|
Acute Tox. 4; Eye Dam. 1 |
Details | |||
|
show/hide
Tris(2-hydroxyethyl)ammonium (o,p-dichlorophenoxy)acetate
EC / List no:
219-911-1
| CAS no:
2569-01-9
Acetic acid, (2,4-dichlorophenoxy)-, compd. with 2-[2-[2-(octadecylamino)ethoxy]ethoxy]ethanol(1:1)
EC / List no:
-
| CAS no:
37937-04-5
|
-
|
-
|
Acute Tox. 4; Eye Dam. 1; Skin Sens. 1 |
Details | ||
|
-
|
-
|
E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) |
Details | |||
|
-
|
-
|
Carc. 1B; Acute Tox. 4 |
Details | |||
|
-
|
-
|
Acute Tox. 4 |
Details | |||
|
-
|
-
|
Acute Tox. 4 |
Details | |||
|
show/hide
|
-
|
-
|
Repr. 1B; Acute Tox. 2; Acute Tox. 3 |
Details | ||
|
show/hide
2-sec-butyl-4,6-dinitrophenol, compound with 2,2'-iminodiethanol (1:1)
EC / List no:
258-532-6
| CAS no:
53404-43-6
2-sec-butyl-4,6-dinitrophenol, compound with 2,2',2''-nitrilotriethanol (1:1)
EC / List no:
229-166-4
| CAS no:
6420-47-9
2-sec-butyl-4,6-dinitrophenol, compound with 1-aminopropan-2-ol (1:1)
EC / List no:
275-931-0
| CAS no:
71735-19-8
|
-
|
-
|
Repr. 1B; Acute Tox. 3; Eye Irrit. 2 |
Details | ||
|
-
|
-
|
Acute Tox. 3 |
Details | |||
|
-
|
-
|
Acute Tox. 3 |
Details | |||
|
-
|
-
|
Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
Details | |||
|
-
|
-
|
C Carcinogenic (article 57a) M Mutagen (article 57b) |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
show/hide
Rosin
A complex combination derived from wood, especially pine wood. Composed primarily of resin acids and modified resin acids such as dimers and decarboxylated resin acids. Includes rosin stabilized by catalytic disproportionation.
EC / List no:
232-475-7
| CAS no:
8050-09-7
Tall-oil rosin
A complex combination derived from tall oil. Composed primarily of tricyclic monocarboxylic acids, mainly abietic and dehydroabietic acids. Includes tall-oil rosin stabilized by catalytic disproportionation.
EC / List no:
232-484-6
| CAS no:
8052-10-6
|
-
|
-
|
Skin Sens. 1 |
Details | ||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||